Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $19 |
| Triangulated Fair Value | $17 |
| 12-mo Scenario PWEV | $18 |
| Implied Return | -11% |
| Forward P/E | 16.6x |
| Market Cap | $37B |
| 52-Week Range | $14 – $22 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Defensive Re-Rate' (8% weight) — targets $29, +53% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($19) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Private-Label / Brand Erosion' (20%) — targets $8.54, -55% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 54% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2025Q2): management +0.29 vs analyst floor +0.09 → delta +0.21 (n=12 mgmt / 7 Q&A; 14th pctile across the S&P book, z -1.1).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2025Q2 | +0.29 | +0.09 | +0.21 |
| 2025Q1 | +0.28 | +0.24 | +0.04 |
| 2024Q4 | +0.31 | +0.01 | +0.30 |
| 2024Q3 | +0.35 | +0.17 | +0.18 |
News (last 365d, 1000 articles): avg ticker sentiment +0.12 (bullish 14% / bearish 4%)
Scenario Analysis
The tree runs from a structural 'Structural — Private-Label / Brand Erosion' downside ($9) to a 'Bull — Defensive Re-Rate' bull case ($29); the probability-weighted blend (PWEV $18) is -4% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 20% | $9 | -55% |
| Consumer / Input Recession | 18% | $15 | -21% |
| Base — Pricing-Led Organic Growth | 34% | $20 | +3% |
| Growth — Premium Innovation + EM | 20% | $25 | +30% |
| Bull — Defensive Re-Rate | 8% | $29 | +53% |
| Probability-Weighted (PWEV) | — | $18 | -4% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Private-Label / Brand Erosion (20%, $9). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 8.54; probability: 0.2.
- Consumer / Input Recession (18%, $15). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising. Drivers — implied_target: 15.17; probability: 0.18.
- Base — Pricing-Led Organic Growth (34%, $20). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns. Drivers — implied_target: 19.63; probability: 0.34.
- Growth — Premium Innovation + EM (20%, $25). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 24.78; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $29). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets. Drivers — implied_target: 29.15; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $16 | -14% |
| Peer P/E re-rate | multiple | $22 | +14% |
| Peer EV/Revenue re-rate | multiple | $8 | -58% |
| Scenario PWEV | multiple | $18 | -4% |
| DCF (5-year + terminal) | cash flow + terminal × | $15 | -23% |
| Triangulated (weighted) | — | $17 | -11% |
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $16 and 36% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (54% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.5%, 14x terminal FCF multiple → $15. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 18.990000000000002x) implies $22. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Household & Personal Care | $15.3B | 100% | 4% | 18% | 16x | 3% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) |
| net_debt_or_cash_b | -7.59 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.044 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | private-label / brand erosion |
| upside | premium innovation + emerging markets |
Industry Context — Consumer Staples — Household
This name sits in the Consumer Staples — Household as a household_personal. branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: PG (household_personal) · CL (household_personal) · KVUE (household_personal) · KMB (household_personal) · EL (household_personal) · CHD (household_personal) · CLX (household_personal)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 38% | 38% | |
| Mid-Cycle — Pricing-Led Organic Growth | 34% | 34% | |
| Upside — Premium Innovation / EM | 28% | 28% |
On the cluster's key downside — Structural — Private-Label / Brand Erosion () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_household cycle is the shared macro driver. Driver — branded HPC pricing power + organic volume + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $16B | $3B | $0B | $0B | $2B | $2B |
| FY+2 | $17B | $3B | $0B | $0B | $2B | $2B |
| FY+3 | $17B | $3B | $1B | $0B | $3B | $2B |
| FY+4 | $18B | $3B | $1B | $0B | $3B | $2B |
| FY+5 | $18B | $3B | $1B | $1B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 14x | $26B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.5% · Σ PV(FCF) $10B + PV(terminal) $26B = EV $36B; + net cash → equity $28B ÷ diluted shares 1.92B = $15/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $21/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 18% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| PG | 4.377x | 21.37x | 4% | 23% |
| EL | 2.404x | 26.04x | 4% | 15% |
| ADM | 0.582x | 16.61x | 2% | 1% |
| KR | 0.376x | 11.16x | 5% | 3% |
| Median | 1.4929999999999999x | 18.990000000000002x | — | — |
Peer-median fwd P/E → $22; EV/Rev → $8.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $15 | 41% | $6 |
| Scenario PWEV | $18 | 29% | $5 |
| Monte Carlo median | $16 | 18% | $3 |
| Peer P/E | $22 | 12% | $3 |
| Triangulated | — | 100% | $17 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 9.8x | 11.9x | 14.0x | 16.1x | 18.2x |
|---|---|---|---|---|---|
| 6% | $12 | $14 | $16 | $19 | $21 |
| 6% | $11 | $13 | $16 | $18 | $20 |
| 8% | $11 | $13 | $15 | $17 | $19 |
| 8% | $10 | $12 | $14 | $16 | $18 |
| 10% | $10 | $11 | $13 | $15 | $17 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $10 | $11 | $13 | $14 | $15 |
| -1.5pp | $11 | $12 | $14 | $15 | $17 |
| +0.0pp | $12 | $13 | $15 | $16 | $18 |
| +1.5pp | $13 | $14 | $16 | $17 | $19 |
| +3.0pp | $14 | $15 | $17 | $19 | $20 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $12 | $18 | $6 |
| Terminal × ±15% | $13 | $17 | $4 |
| Revenue CAGR ±3pp | $13 | $17 | $4 |
| WACC ±1pp | $14 | $16 | $2 |
| FCF conversion ±10% | $15 | $15 | $0 |
Company lever — SoP/share vs Household & Personal Care multiple (AI re-rating) (base 16x)
| Multiple | 11.2x | 13.6x | 16.0x | 18.4x | 20.8x |
|---|---|---|---|---|---|
| SoP/share | $85 | $104 | $124 | $143 | $162 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 14×, FY+5 revenue $18B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (54% of variance); a de-rating toward the DCF anchor ($15) implies -23%.
Fact / Inference / Speculation
- FACT: Spot $19; 52-week range $14–$22; engine rating HOLD; base-case target $18 (-4%).
- INFERENCE: Triangulated FV $17 (-11%). P/E Multiple explains 54% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 54% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $17 (-11% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (54% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).